Robotic pancreatectomy for pancreatic adenocarcinoma: evolving trends in patient selection and practice patterns across a decade
HPB · 2025
DOI: 10.1016/j.hpb.2025.06.009 ↗Kurz gefasst
Fachartikel in der Zeitschrift HPB, 2025. Verfasst von Paul Wong und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Surgical Oncology, Department of Surgery, University of California, San Francisco, United States; Division of Surgical Oncology, Departme…. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Robotic Surgical Procedures, Pancreatectomy, Adenocarcinoma. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Robotic surgery has been developed as an additional minimally invasive approach to pancreatectomy. We assessed case selection and perioperative outcomes in patients undergoing robotic pancreatectomy for pancreatic adenocarcinoma over time. METHODS: The National Cancer Database (2010-2019) was queried to identify all pancreatic adenocarcinoma patients that underwent robotic pancreatoduodenectomy (RPD) or distal pancreatectomy (RDP). Two periods were established: Early cohort (2010-2014) and Modern cohort (2015-2019). RESULTS: Of 2245 patients who underwent RPD or RDP, 78.4 % of RPD and 77.6 % of RDP were in the Modern cohort. Robotic approach increased from 2010 to 2019 (RPD: 1.1 %-7.5 %, RDP: 2.2 %-19.4 %; both p < 0.001). Compared to Early, Modern RPD patients were more likely to have non-private insurance (68.5 % vs. 58.7 %), and both RPD (47.0 % vs. 23.4 %) and RDP (47.3 % vs. 32.1 %) patients were more frequently treated in non-academic hospitals (all p < 0.01). Shorter LOS was noted in the Modern RPD (6 vs. 8 days) and RDP cohorts (5 vs. 6 days, both p < 0.001), without differences in readmission/mortality. In RPD and RDP, no differences in overall survival were observed between the eras. CONCLUSIONS: Robotic pancreatectomy for pancreatic adenocarcinoma has increased over time with greater inclusion of patients and hospital types while outcomes have remained similar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Surgical Oncology, Department of Surgery, University of California, San Francisco, United States; Division of Surgical Oncology, Department of Surgery, City of Hope Medical Center, United States. Electronic…
- Division of Surgical Oncology, Department of Surgery, City of Hope Medical Center, United States.
- Division of Surgical Oncology, Department of Surgery, University of California, San Francisco, United States.
Zitieren
APA
Wong, P., Lewis, A., Thornblade, L. W., Maker, A. V., Fong, Y., & Melstrom, L. G. (2025). Robotic pancreatectomy for pancreatic adenocarcinoma: evolving trends in patient selection and practice patterns across a decade. HPB. https://doi.org/10.1016/j.hpb.2025.06.009
Vancouver
Wong P, Lewis A, Thornblade LW, Maker AV, Fong Y, Melstrom LG. Robotic pancreatectomy for pancreatic adenocarcinoma: evolving trends in patient selection and practice patterns across a decade. HPB. 2025. doi:10.1016/j.hpb.2025.06.009
BibTeX
@article{Wong2025,
author = {Wong, Paul and Lewis, Aaron and Thornblade, Lucas W and Maker, Ajay V and Fong, Yuman and Melstrom, Laleh G},
title = {Robotic pancreatectomy for pancreatic adenocarcinoma: evolving trends in patient selection and practice patterns across a decade},
journal = {HPB},
year = {2025},
doi = {10.1016/j.hpb.2025.06.009}
}
EUVIMED